{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"68","value":"9.50"},{"comment":"Unable to calculate geometric coefficient of variation due to low number of participants","groupId":"OG001","spread":"NA","value":"2.39"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 2 Day 1 - BMS986016"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"66","value":"20.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 4 Day 1 - BMS986016"},{"categories":[{"measurements":[{"comment":"Unable to calculate geometric coefficient of variation due to low number of participants","groupId":"OG000","spread":"NA","value":"23.53"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 6 Day 1 - BMS986016"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"46","value":"40.32"},{"comment":"Unable to calculate geometric coefficient of variation due to low number of participants","groupId":"OG001","spread":"NA","value":"17.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 2 Day 1 - BMS-936558"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"53","value":"79.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 4 Day 1 - BMS-936558"},{"categories":[{"measurements":[{"comment":"Unable to calculate geometric coefficient of variation due to low number of participants","groupId":"OG000","spread":"NA","value":"91.87"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 6 Day 1 - BMS-936558"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"Concentration Trough (Ctrough) for Analyte BMS-986016 and BMS-936558","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received treatment with Relatlimab 160 mg + Nivolumab 480 mg Q4W","id":"OG000","title":"Part A - Flat Dosing (AF)"},{"description":"Participant received treatment with Relatlimab 2 mg/kg + Nivolumab 6 mg/kg Q4W","id":"OG001","title":"Part A - Age/Weight-based Dosing (AW)"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"PK Population","reportingStatus":"POSTED","timeFrame":"Cycle 2 Day 1, Cycle 4 Day 1, Cycle 6 Day 1","title":"Concentration Trough (Ctrough)","type":"PRIMARY","unitOfMeasure":"ug/mL"}